The present study demonstrated that TREM2 modulates high glucose-induced microglial inflammation via the NLRP3 signaling pathway providing evidence for the study of chronic neuroinflammation and the immunometabolic response in diabetes neuroinflammation. The gene discussed is NLRP3; the disease is diabetes mellitus.